Day: March 8, 2023

PRESS RELEASE Neuilly-sur-Seine, France – March 8, 2023 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMFDate Number of shares(1) Number of voting rights28/02/2023 452,523,923 Theoretical number of voting rights: 622,206,482 Number of exercisable voting rights: 622,075,700  (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2023.                Bureau Veritas Head Office Tel: + 33 (0)1 55 24 70 00Société Anonyme Immeuble Newtime Fax: + 33 (0)1 55 24 70 01(Limited liability corporation) 40/52 boulevard du Parc www.bureauveritas.comShare capital of EUR 54,293,334.48 92200 Neuilly-sur-Seine  RCS Nanterre 775 690 621 France  Attachment...

Company announcement no. 5 – 238 March 2023 NTG Nordic Transport Group Annual Report for 2022 NTG Nordic Transport Group A/S (“NTG”) has today published the 2022 annual report. Selected financial highlights are presented below:    Full year   Q4(DKKm)   2022 2021   2022 2021Net revenue   10,224 7,302   2,496 2,172Gross profit   2,012 1,474   518 443Operating profit before special items (adj. EBIT)   758 542   173 161Profit for the year   535 385      Earnings per share (DKK)   21.77 15.64                   Gross margin   19.7% 20.2%   20.8% 20.4%Operating margin   7.4% 7.4%   6.9% 7.4%Conversion ratio   37.7% 36.8%   33.4% 36.3%ROIC before tax   46.0%...

CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that an article was recently published in Epilepsia showed that perampanel reduces seizures with high effectivity in patients with rare genetic epileptic disease. The article is available online at https://onlinelibrary.wiley.com/doi/10.1111/epi.17530. The case review from a group of European neurologists treating rare epilepsies working under the framework of NETRE (Network for Therapy in Rare Epilepsies) reports how perampanel (FYCOMPA®) is capable of significantly reducing seizures in patients with epilepsies...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES TORONTO, March 08, 2023 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) announces that it has received notification that a receiver (the “Receiver”) is in the process of being appointed with respect to the 24,691,628 common shares of the Company that are registered in the name of Purple Star Holdings Limited. Century understands that the Receiver will be appointed pursuant to a loan for which the shares were pledged as security. Century understands that a Form 45-102F1 – Notice of Intention to Distribute Securities under Section 2.8 of NI 45-102 has been filed in respect of these shares. Century also anticipates that the Receiver will file an early warning report and issue a press release upon...

TORONTO, March 08, 2023 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) invites you to join our conference call following the release of our Q4 and year-end 2022 financials results on Tuesday, March 14th, 2023 at 11:00 AM EST, where management will discuss our financial results and project developments and follow with a question-and-answer session. Questions can be asked directly by participants over the phone during the webcast.Tuesday Mar 14th 2023 at 11:00 AM ESTToll Free (US & Canada): (888) 330-2398Outside US & Canada: (240) 789-2709Conference ID Number: 67121Event Registration Link: https://conferencingportals.com/event/ZSafhHZiWebcast Link: https://events.q4inc.com/attendee/387697089An archived replay of the webcast will be available approximately 4 hours following the conclusion...

HighlightsIncrease in adjusted operating earnings before depreciation and amortization in the Packaging Sector more than offset by a slowdown in the Printing Sector. Revenues of $707.0 million for the quarter ended January 29, 2023; operating earnings of $15.0 million; and net earnings attributable to shareholders of the Corporation of $1.0 million ($0.01 per share). Adjusted operating earnings before depreciation and amortization(1) of $84.1 million for the quarter ended January 29, 2023; adjusted operating earnings(1) of $41.8 million; and adjusted net earnings attributable to shareholders of the Corporation(1) of $21.1 million ($0.24 per share). Implemented initiatives generating savings of over $15.0 million in fiscal 2023. Maintained the quarterly dividend at $0.225 per share ($0.90 per year). Entered into an outsourcing agreement...

Amsterdam, 8 March 2023: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announces its support to “BeSafe” campaign to protect Ukrainian women and children from the risks of human trafficking.  VEON, through its Ukrainian digital operator Kyivstar, is joining the campaign by instigating a messaging system to alert and protect potentially vulnerable Ukrainians by increasing awareness and enabling reporting of risks. BeSafe is an awareness and protection campaign organised by the Organization for Security and Cooperation in Europe (OSCE) and Thomson Reuters to provide Ukrainians with critical information on how they can spot the warning signs of traffickers, minimize the risks and get assistance through crisis hotlines in 12 European countries. To...